资讯
Grace Therapeutics, Inc. has announced positive results from its Phase 3 STRIVE-ON trial for GTx-104, an injectable formulation of nimodipine aimed at treating aneurysmal Subarachnoid Hemorrhage ...
Nimodipine 30mg; soft-gel caps. Take on empty stomach. 60mg every 4 hours for 21 consecutive days. Start within 96 hours of subarachnoid hemorrhage. If oral therapy is not feasible, may extract ...
Magnesium sulfate may prevent eclampsia by reducing cerebral vasoconstriction and ischemia. Nimodipine is a calcium-channel blocker with specific cerebral vasodilator activity. Our objective was ...
(Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, novel, injectable formulation of nimodipine being developed for IV infusion to address ...
NIMOTOP (nimodipine) is a calcium channel blocker indicated for patients with subarachnoid hemorrhage. It improves neurological outcome by relaxing cerebral smooth muscle vasculature and ...
Nimodipine is a calcium channel blocker, prescribed for brain hemorrhage (bleeding in the brain) and also rarely used for high blood pressure. We recommend consulting your doctor to verify the ...
Even slight injuries can kill the sensitive cells. The drug nimodipine could help prevent this. It is currently being used to treat cerebral hemorrhages. The drug relaxes blood vessels which can ...
The study's primary objective was to evaluate the relative bioavailability of IV GTX-104 compared to oral nimodipine in healthy subjects, while the secondary objective was to assess its safety and ...
Details concerning the Nimodipine medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, liquids, and injections.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果